Galmed Pharmaceuticals Ltd. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2022 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Galmed Pharmaceuticals Ltd. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2022 to Q2 2024.
  • Galmed Pharmaceuticals Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 6.29M shares, a 275% increase year-over-year.
  • Galmed Pharmaceuticals Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.77M shares, a 65.2% increase from 2022.
  • Galmed Pharmaceuticals Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.68M shares, a 2.22% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 6.29M +4.61M +275% Apr 1, 2024 Jun 30, 2024 6-K 2024-08-28
Q2 2023 1.68M +7.67K +0.46% Apr 1, 2023 Jun 30, 2023 6-K 2024-08-28
Q2 2022 1.67M Apr 1, 2022 Jun 30, 2022 6-K 2023-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.